Video Experimental Relacionado
Updated: May 10, 2026
09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
HIF1A emplea el mediador CDK8 para estimular el alargamiento de RNAPII en respuesta a la hipoxia
Matthew D Galbraith1, Mary A Allen, Claire L Bensard
1Howard Hughes Medical Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.
Cell
|June 11, 2013
Resumen
El factor 1-alfa inducible a la hipoxia (HIF1A) utiliza el complejo CDK8-Mediator para mejorar el alargamiento de la ARN polimerasa II (RNAPII), un paso clave en la respuesta celular a la falta de oxígeno.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
- La bioquímica es la bioquímica.
Sus antecedentes:
- El factor 1-alfa inducible a la hipoxia (HIF1A) es crucial para la adaptación celular a condiciones de bajo oxígeno.
- Los mecanismos precisos por los cuales HIF1A regula la expresión génica, particularmente la actividad de la ARN polimerasa II (RNAPII), siguen siendo incompletamente entendidos.
Objetivo del estudio:
- Para aclarar el papel de HIF1A en la regulación de la actividad de RNAPII durante la hipoxia.
- Para identificar los componentes específicos del complejo Mediador involucrado en la inducción de genes mediada por HIF1A.
Principales métodos:
- Los ensayos de inmunoprecipitación de cromatina (ChIP, por sus siglas en inglés) evalúan la unión a las proteínas.
- Análisis global de RNAPII activo para cuantificar los cambios en la expresión génica.
- Ensayos bioquímicos para estudiar las interacciones de las proteínas.
Principales resultados:
- HIF1A recluta el complejo CDK8-Mediator para estimular el alargamiento de RNAPII, independientemente de su unión a la cromatina o la acetilación de histonas.
- CDK8, pero no CDK19, es esencial para la inducción de los genes diana HIF1A.
- HIF1A promueve la unión del complejo de súper elongación (SEC) a través del mediador CDK8, aliviando así la pausa del RNAPII.
Conclusiones:
- HIF1A utiliza el complejo CDK8-Mediator para controlar el alargamiento de RNAPII y la expresión génica durante la hipoxia.
- CDK8 actúa como un mediador crítico que vincula la señalización HIF1A con la activación transcripcional.
- Estos hallazgos revelan un nuevo mecanismo que involucra a HIF1A y CDK8 en la respuesta de hipoxia y la biología del cáncer.
Videos de Conceptos Relacionados
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.